Skip to content
2000
Volume 1, Issue 1
  • ISSN: 1872-3128
  • E-ISSN: 1874-0758

Abstract

We investigated the role of NAT2 on clonazepam acetylation, using transiently expressed human NAT2 alleles. The NAT25*B and the NAT2*6A variant alleles cause a 20 and 22-fold reduction in the Vmax, respectively. We conclude that NAT2 is responsible for 7-aminoclonazepam acetylation and that NAT2 gene polymorphisms impair such metabolic pathway.

Loading

Article metrics loading...

/content/journals/dml/10.2174/187231207779814283
2007-01-01
2025-10-20
Loading full text...

Full text loading...

/content/journals/dml/10.2174/187231207779814283
Loading

  • Article Type:
    Research Article
Keyword(s): acetylation; NAT2; pharmacogenomics; polymorphism
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test